NOV 20, 2018 07:00 AM PST

COLD-PCR technology: current status and application in liquid biopsies for cancer and prenatal diagnosis

SPONSORED BY: Perkin Elmer
C.E. CREDITS: P.A.C.E. CE | Florida CE
Speakers
  • Professor and Director of the Medical Physics & Biophysics division in Radiation Oncology at Dana Farber Cancer Institute and Brigham and Women's Hospitals, Harvard Medical School
    Biography
      Dr. Makrigiorgos is a Professor and Director of the Medical Physics & Biophysics division in Radiation Oncology at Dana Farber Cancer Institute and Brigham and Women's Hospitals, Harvard Medical School. He is as ABR-certified radiation oncology physicist and he also directs his DNA technology laboratory and a radiation pre-clinical facility. His research interests include the development of novel DNA technologies for molecular diagnostics in Oncology and the detection of circulating cancer biomarkers. Funded continuously by NIH over the last 25 years, he invented several new techniques for molecular diagnostics, including Balanced-PCR, COLD-PCR and NaME-PrO. He is a Member of the Editorial Board of Clinical Chemistry and has published over 150 articles in journals including Nature Medicine, Nature Biotechnology, Nucleic Acid Research and Clinical Chemistry. He received his undergraduate degree in Physics from the University of Athens, Greece, his PhD in Medical Physics from the University of Leeds, UK and his postdoctoral training in radiation biology from Harvard Medical School, Boston.

    Abstract:

    DATE: November 20, 2018
    TIME: 07:00 PST

    Since its original development (2008) COLD-PCR has been used by several groups for increasing the sensitivity of mutation detection in different settings including cancer diagnostics and prenatal screening. This webinar will review the principle and basic improvements in the technology over the years and will describe envisioned clinical applications in liquid biopsies.

    Learning Objectives:

    • Learn about COLD-PCR principles
    • Understand COLD-PCR application in DNA diagnostics
    • Understand the comparison with other technologies

    Show Resources
    You May Also Like
    MAY 24, 2018 09:30 AM PDT
    C.E. CREDITS
    MAY 24, 2018 09:30 AM PDT
    DATE: May 24, 2018 TIME: 9:30PM PDT The current gold standard in in vitro pre-clinical cancer treatment screening remain cell lines,...
    AUG 15, 2018 08:00 AM PDT
    C.E. CREDITS
    AUG 15, 2018 08:00 AM PDT
    DATE: August 15, 2018TIME: 08:00AM PDT, 11:00AM EDTThe failure of current chemotherapeutic strategies in the fight against cancer can be largely attributed to the occurrence of drug res...
    JUN 26, 2018 06:00 AM PDT
    C.E. CREDITS
    JUN 26, 2018 06:00 AM PDT
    Date: June 26, 2018Time: 6:00 a.m. PDT, 9:00 a.m. EDT, 1500 CEST Today’s hematology analyzers employ various methods for enumerating platelets. These methods include: e...
    APR 27, 2018 10:00 AM PDT
    C.E. CREDITS
    APR 27, 2018 10:00 AM PDT
    DATE: April 27, 2018TIME: 10:00am PST, 1:00pm ESTGlioblastoma (GBM) and Medulloblastoma (MB) are the most common adult and paediatric brain tumours, both of which can have devastating c...
    JUN 20, 2018 10:00 AM EDT
    C.E. CREDITS
    JUN 20, 2018 10:00 AM EDT
    DATE: June 20, 2018TIME: 07:00AM PDT, 10:00AM EDTIntroducing GE’s New Lyo-StableTM service. Sepsis is one of the top challenges facing hospitals in terms of clinical outcomes...
    MAY 24, 2018 09:00 AM PDT
    C.E. CREDITS
    MAY 24, 2018 09:00 AM PDT
    Recent advances in immuno-oncology research has proven the critical role of immune cells in cancer therapy. Deep understanding of the interaction and phenotype of immune and tumor cells withi...
    Loading Comments...